Showing results (3761-3770 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 12, 2009
Prognostic relevance of metabolic approach in patients with heart failureP Di Napoli, A BarsottiCurrent Pharmaceutical Design|March 12, 2009
Cancer drug development using glucose metabolism radiopharmaceuticalsY Y Sun, Y ChenCurrent Pharmaceutical Design|March 12, 2009
Development of a PBPK model for monoclonal antibodies and simulation of human and mice PBPK of a radiolabelled monoclonal antibodyTomi Heiskanen, Tomas Heiskanen, Kalevi KairemoCurrent Pharmaceutical Design|May 16, 2009
The role of gut microbiota in drug responseI D Wilson, J K NicholsonCurrent Pharmaceutical Design|May 16, 2009
The role of the gastrointestinal microbiota in colorectal cancerIan R RowlandCurrent Pharmaceutical Design|May 16, 2009
The gut microbiota in inflammatory bowel diseaseG T Macfarlane, K L Blackett, T Nakayama, et al.Current Pharmaceutical Design|May 16, 2009
Targeting glutamatergic signaling for the development of novel therapeutics for mood disordersRodrigo Machado-Vieira, Giacomo Salvadore, Lobna A Ibrahim, et al.Current Pharmaceutical Design|May 16, 2009
Tachykinin receptors as therapeutic targets in stress-related disordersKarl Ebner, Simone B Sartori, Nicolas SingewaldCurrent Pharmaceutical Design|May 16, 2009
Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugsHan-Ting ZhangCurrent Pharmaceutical Design|May 16, 2009
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and painJ Dunlop, D Vasilyev, P Lu, et al.Pageof 1,008